According to the World Health Organization, 116 million women globally (3.4%) are affected by Polycystic Ovary Syndrome (PCOS), with the condition impacting 1 in 10 women of reproductive age. This represents a severely underserved market with significant barriers to care:

Current Market Failures

🔍 Delayed Diagnosis: Average 2+ years to receive proper diagnosis
⚕️ Fragmented Care: No standardized treatment protocols
📊 Limited Data: Lack of comprehensive patient monitoring
💔 Mental Health Impact: 60% of patients report anxiety/depression
💊 Complex Management: Multiple comorbidities requiring coordinated care

The Solution: Balm.ai Platform

We're building a comprehensive AI-powered health platform that revolutionizes PCOS care through:

Core Technology

AI-Powered Symptom Tracking
- Real-time monitoring and analysis
- Predictive health patterns
- Early warning system for complications
Personalized Treatment Engine
- Custom care protocols
- AI-driven lifestyle recommendations
- Medication optimization
Integrated Care System
- Wearable device integration
- Healthcare provider portal
- Community support network

The Opportunity

By investing in Balm.ai, you're not just backing a technology platform – you're supporting a revolution in women's healthcare. We're building the future of PCOS management, where every woman has access to:

Personalized care protocols
Real-time health insights
Expert support network
Evidence-based treatments

Next Steps

Join us in transforming PCOS care for millions of women worldwide.

Contact: pcoscare@balm.ai

PCOS App for Women

By Balm.ai

PCOS App for Women

Fundraising to build a mobile App for women living with PCOS